Wegovy, an effective weight-loss injection, is restricted by the NHS due to high costs, limiting access for millions.

Wegovy, a weight-loss injection, helped 62-year-old Ray lose 14kg in five months, but the NHS restricts access due to high costs. Only a fraction of the 3.4 million eligible patients in England can receive the drug, limited to two years per patient. Introducing the drug to all eligible individuals would cost £10 billion annually, potentially bankrupting the NHS. A second drug, Mounjaro, approved by NICE, faces similar rollout challenges to avoid overwhelming health services.

2 months ago
6 Articles